Elizabeth Holmes, the convicted founder of Theranos, is currently serving an 11-year prison sentence for defrauding investors. Despite her legal troubles, she is advising her partner Billy Evans on his new startup, Haemanthus, which focuses on innovative medical testing technology. This venture has attracted millions in funding and utilizes advanced AI sensors for diagnostic purposes, reminiscent of her earlier failed company. While the technology claims to perform tests using minimal blood samples, it revives questions about the promises of accuracy and reliability in the field of biotech.
Elizabeth Holmes, despite serving a prison sentence for fraud, is supporting her partner's new medical startup, Haemanthus, which echoes the technology of Theranos.
Holmes provides advice for Haemanthus, a startup focused on medical testing using innovative AI technology, yet it raises concerns reminiscent of her past ventures.
Collection
[
|
...
]